Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 3/20 | 0.64 |
| ▸ | PIK3CD | O00329 | 4/20 | 0.59 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.57 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.57 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29568613 | 1.00 | MAP4K4 (0.64) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL20704158 | 0.98 | MAP4K4 (0.62) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL17027804 | 0.92 | MAP4K4 (0.72) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL30337416 | 0.90 | PIK3CD (0.70) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL29740321 | 0.87 | PIK3CD (0.73) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL1257460 | 0.87 | PIK3CD (0.73) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL21190373 | 0.86 | PIK3CD (0.50) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL29504964 | 0.85 | MAP4K4 (0.50) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL1256963 | 0.83 | PIK3CD (0.61) | MAP4K4PIK3CDMKNK1MKNK2LTA4H | |
| SCHEMBL30502351 | 0.83 | PIK3CD (0.61) | MAP4K4PIK3CDMKNK1MKNK2LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113694906-B | Magnetic sulfonic acid functionalized Fe 3 O 4 @SHCP adsorbent and preparation method and application thereof | 桂林医学院附属医院 | 2023-10-24 | — | — | CN | claimed |
| CN-116671604-A | Coating for inhibiting formation of harmful substances in processing process of roast chicken and preparation method thereof | 湖南农业大学长沙现代食品创新研究院 | 2023-09-01 | — | — | CN | claimed |
| CN-112881568-A | Method for simultaneously determining multiple associated harmful substances in food thermal processing | 大连工业大学 | 2021-06-01 | — | — | CN | claimed |
| CN-104262244-B | A kind of 5-phenylpyridine-2-amine Bcr-Abl inhibitor and its preparation method and application | Xi''an Jiao Tong University (CN) | 2017-01-04 | — | — | CN | claimed |
| CN-104262244-A | 5-phenylpyridine-2-amine Bcr-Abl inhibitors as well as preparation method and application thereof | UNIV XI AN JIAOTONG | 2015-01-07 | — | — | CN | claimed |
| US-20030144518-A1 | Process for preparing 3-acylamino-imidazo[1,2-a]pyridines | THE PROCTER & GAMBLE COMPANY | 2003-07-31 | — | — | US | claimed |
| WO-2003013523-A1 | SH3 PROTEIN DOMAINS AND THEIR LIGANDS | ADELAIDE RESEARCH & INNOVATION PTY LTD (AU) | 2003-02-20 | — | — | WO | claimed |
| US-5972975-A | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase | MERCK & CO., INC. (US) | 1999-10-26 | — | — | US | claimed |
| WO-1996018616-A1 | SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE | MERCK & CO., INC. (US) | 1996-06-20 | — | — | WO | claimed |
| JP-11071372-A | — | — | None | — | — | JP | disclosed |
| CN-122079881-A | Pyridone derivatives and uses thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4615839-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | Bristol-Myers Squibb Company (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250263404-A1 | AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE | UCL BUSINESS LTD (GB) | 2025-08-21 | — | — | US | disclosed |
| US-12391663-B2 | Isoindolinone compounds | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-19 | — | — | US | disclosed |
| EP-0098684-A2 | Modified chichibabin reaction, and novel pyridine derivatives | REILLY INDUSTRIES, INC. (US) | 1984-01-18 | — | — | EP | disclosed |
| US-4405552-A | INSECTICIDES | ELI LILLY AND COMPANY (US) | 1983-09-20 | — | — | US | disclosed |
| US-4386209-A | Chichibabin reaction | REILLY TAR & CHEMICAL CORPORATION (US) | 1983-05-31 | — | — | US | disclosed |
| EP-0060071-A1 | Improvements in or relating to 1-benzoyl-3-(arylpyridyl)urea compounds | ELI LILLY AND COMPANY (US) | 1982-09-15 | — | — | EP | disclosed |
| US-4192944-A | ANTIANAPHYLACTIC | BRISTOL-MYERS COMPANY (US) | 1980-03-11 | — | — | US | disclosed |
| US-4122274-A | ANTIALLERGY | BRISTOL-MYERS COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144518-A1 | Process for preparing 3-acylamino-imidazo[1,2-a]pyridines | CBR1, PTGS1, CBR3 | MAP4K4 2598/4885PIK3CD 3111/4885MKNK1 4399/4885 |
| US-12391663-B2 | Isoindolinone compounds | CYP4F2, AOC2, AOC3 | MAP4K4 3212/4885PIK3CD 3205/4885MKNK1 3289/4885 |
| US-20250263404-A1 | AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE | PIK3CD, PTEN, PIK3CG | MAP4K4 295/4885PIK3CD 1/4885MKNK1 307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.